+54,665.2%
TSCO vs GSK
+869.9%
+53,795.3%
-76.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | -0.1% | -0.6% | -0.7% |
| 7D | +5.5% | -5.3% | +10.8% | +6.9% |
| 30D | +17.6% | -3.7% | +21.2% | +18.7% |
| 3M | +10.4% | -7.3% | +17.7% | +12.4% |
| 6M | +23.1% | -4.2% | +27.4% | +24.0% |
| YTD | -21.6% | +0.9% | -22.5% | -22.2% |
| 1Y | -25.2% | +7.3% | -32.5% | -26.9% |
| 3Y | +1.5% | +52.7% | -51.3% | -10.6% |
| 5Y | -8.8% | +40.1% | -48.9% | -18.7% |
| 10Y | +209.3% | +98.7% | +110.6% | +148.5% |
| All | +54,665.2% | +869.9% | +53,795.3% | +29,609.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling